certify

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

July 13, 2023 212 Views
After positive data in an early-stage trial, AbbVie and Genmab plan to ask the Food and Drug Administration ...
May 9, 2020 2563 Views
More than a year since AbbVie first announced its intentions to acquire Botox maker, Allergan, for $63 billion, ...
June 26, 2019 3294 Views
After facing shareholder pressure to either break up the company or sell it, Allergan Chairman and Chief Executive ...
December 21, 2018 4901 Views
AbbVie has granted Pfizer a non-exclusive license to market its Humira (adalimumab) biosimilar in the U.S., which will ...
November 25, 2018 11860 Views
Mission Therapeutics (“Mission”), a drug creator company focused on selectively targeting deubiquitylating enzymes (DUBs) and Chicago-based AbbVie (“AbbVie”), ...
November 20, 2018 14094 Views
On November 13th, Chicago-based AbbVie, a research-based global biopharmaceutical company, released new findings on its pan-genotypic chronic hepatitis C ...
banner
Adsense